References
- Arteaga, Perez Ignacia 2022. “Game-Changing? When Biomarker Discovery and Novel Forms of Patient Work Meet.” Medical Anthropology 41 (2), 156–168. doi:https://doi.org/10.1080/01459740.2020.1860960.
- Baszanger, Isabelle. 1986. “Les Maladies Chroniques et Leur Ordre Négocié.” Revue Française de Sociologie 27 (1): 3–27. [Chronic illnesses and their negotiated order]. doi:https://doi.org/10.2307/3321642.
- Baszanger, Isabelle. 2000. “Entre Traitement de la Dernière Chance et Palliatif Pur: les Frontières Invisibles Des Innovations Thérapeutiques.” Sciences Sociales et Santé 18 (2): 67–94. [The invisible boundaries of therapeutic inovation]. doi:https://doi.org/10.3406/sosan.2000.1491.
- Baszanger, Isabelle. 2012. “One More Chemo or One Too Many? Defining the Limits of Treatment and Innovation in Medical Oncology.” Social Science & Medicine (1982) 75 (5): 864–872. doi:https://doi.org/10.1016/j.socscimed.2012.03.023.
- Bergeron, Henry, and Patrick Castel. 2010. “Captation, Appariement, Réseau: une Logique Professionnelle D’organisation Des Soins.” Sociologie du Travail 52 (4): 441–460. [Acquisitiveness, match, network: The professional logic of the organization of care.] doi:https://doi.org/10.1016/j.soctra.2010.09.001.
- Besle, Sylvain, and Aline, Sarradon-Eck. 2019. “Choisir le risque : l’autonomie du malade en situation d’échec thérapeutique.” [Opting for risk: patients’ autonomy when conventional treatment has failed] Anthropologie & Santé 19. doi:https://doi.org/10.4000/anthropologiesante.4817
- Brives, Charlotte. 2013. “Identifying Ontologies in a Clinical Trial.” Social Studies of Science 43 (3): 397–416. doi:https://doi.org/10.1177/0306312712472406.
- Brown, Patrick, Sabine de Graaf, and Marij Hillen. 2015. “The Inherent Tensions and Ambiguities of Hope: Towards a Post-Formal Analysis of Experiences of Advanced-Cancer Patients.” Health (London, England : 1997) 19 (2): 207–225. doi:https://doi.org/10.1177/1363459314555241.
- Burke, Nancy J. 2014. “Rethinking the Therapeutic Misconception: Social Justice, Patient Advocacy, and Cancer Clinical Trial Recruitment in the US Safety Net.” BMC Medical Ethics 15: 68. doi:https://doi.org/10.1186/1472-6939-15-68.
- Burke, Nancy J., and Holly F. Mathews. 2017. “Returning to Earth: Setting a Global Agenda for the Anthropology of Cancer.” Med Anthropol 36 (3): 179–186. doi:https://doi.org/10.1080/01459740.2016.1255611.
- Bury, Mike. 1982. “Chronic Illness as Biographical Disruption.” Sociology of Health & Illness 4 (2): 167–182. doi:https://doi.org/10.1111/1467-9566.ep11339939.
- Bury, Mike. 1991. “The Sociology of Chronic Illness: A Review of Research and Prospects.” Sociology of Health and Illness 13 (4): 451–182. doi:https://doi.org/10.1111/j.1467-9566.1991.tb00522.x.
- Bury, Mike, and Lee F. Monaghan. 2013. “Chronic Illness.” In Key Concepts in Medical Sociology, edited by Jonathan Gabe and Lee F. Monaghan, 72–81. LA/London/New Delhi/Singapore: Sage.
- Castel, Patrick. 2005. “Le Médecin, Son Patient et Ses Pairs. Une Nouvelle Approche de la Relation Thérapeutique.” Physicians, Their Patients, and Their Peers a New Approach to the Therapeutic Relation.” Revue Française de Sociologie 46 (3): 443–467. doi:https://doi.org/10.3917/rfs.463.0443.
- Cortez, Dagoberto, and Michael Halpin. 2020. “Uncertainty and Certain Death: The Role of Clinical Trials in Terminal Cancer Care.” Sociology of Health & Illness 42 (S1): 130–115. doi:https://doi.org/10.1111/1467-9566.13059.
- DelVecchio Good, Mary-Jo. 2001. “The Biotechnical Embrace.” Culture, Medicine and Psychiatry 25 (4): 395–410. doi:https://doi.org/10.1023/A:1013097002487.
- Epstein, Steven. 1995. “The Construction of Lay Expertise: AIDS Activism and the Forging of Credibility in the Reform of Clinical Trials.” Science, Technology & Human Values 20 (4): 408–437. doi:https://doi.org/10.1177/016224399502000402.
- Fassin, Dider. 1992. Pouvoir et Maladie en Afrique [Power and illness in Africa]. Paris: PUF.
- Fox, Renée Claire. 1959. Experiment Perilous: Physicians and Patients Facing the Unknown. Glencoe, Il: Free Press.
- Gaston, Christine M., and Geoffrey Mitchell. 2005. “Information Giving and Decision-Making in Patients with Advanced Cancer: A Systematic Review.” Social Science & Medicine (1982) 61 (10): 2252–2264. doi:https://doi.org/10.1016/j.socscimed.2005.04.015.
- Glaser, Barney, and Anselm Strauss. 1975. Chronic Illness and the Quality of Life. St Louis: Mosby, Hardon.
- Hardon, Anita, and Eileen Moyer. 2014. “Medical Technologies: Flows, Frictions and New Socialities.” Anthropology & Medicine 21 (2): 107–112. doi:https://doi.org/10.1080/13648470.2014.924300.
- Hughes, Everett C. 1950. “Cycles, Turning Points, and Careers.” Eighth Annual Conference on Theology in Action, South Byfield, Massachusetts, 124–131.
- Huguet, Marius. 2020. “Centralization of Care in High Volume Hospitals and Inequalities in Access to Care.” Social Science & Medicine (1982) 260: 113177–113177. doi:https://doi.org/10.1016/j.socscimed.2020.113177.
- Jansen, Lynn A. 2014. “Mindsets, Informed Consent, and Research.” Hastings Center Report 44 (1): 25–32. doi:https://doi.org/10.1002/hast.237.
- Joseph, Galen, and Daniel Dohan. 2012. “Recruitment Practices and the Politics of Inclusion in Cancer Clinical Trials.” Medical Anthropology Quarterly (New Series), 26 (3): 338–360. doi:https://doi.org/10.1111/j.1548-1387.2012.01222.x.
- Kaspar, Heidi. 2019. “Searching for Therapies, Seeking for Hope: Transnational Cancer Care in Asia.” Mobilities 14 (1): 120–136. doi:https://doi.org/10.1080/17450101.2018.1533688.
- Kaufman, Sharon R., Paul S. Mueller, L. Ottenberg Abigale, and Barbara A. Koenig. 2011. “Ironic Technology: Old Age and the Implantable Cardioverter Defibrillator in US Health Care.” Social Science & Medicine (1982) 72 (1): 6–14. doi:https://doi.org/10.1016/j.socscimed.2010.09.052.
- Keating, Peter, and Alberto Cambrosio. 2012. Cancer on Trial Oncology as a New Style of Practice. Chicago: University of Chicago Press.
- Kerr, Anne, and Sarah Cunningham-Burley. 2015. “Embodied Innovation and Regulation of Medical Technoscience: Transformations in Cancer Patienthood.” Law, Innovation and Technology 7 (2): 187–205. doi:https://doi.org/10.1080/17579961.2015.1106103.
- Kerr, Anne, Emily Ross, Gwen Jacques, and Sarah Cunningham-Burley. 2018. “The Sociology of Cancer: A Decade of Research.” Sociology of Health & Illness 40 (3): 552–576. doi:https://doi.org/10.1111/1467-9566.12662.
- Lage, Agustin, and Tania Crombet. 2011. “Control of Advanced Cancer: The Road to Chronicity.” International Journal of Environmental Research and Public Health 8 (3): 683–697. doi:https://doi.org/10.3390/ijerph8030683.
- Manderson, Leonore. 2011. “Anthropologies of Cancer and Risk, Uncertainty and Disruption.” In A Companion to Medical Anthropology, edited by Merrill Singer and Pamela I. Erickson, 323–338. London: Wiley Blackwell.
- Marks, Harry M. 1997. The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990 (Cambridge History of Medicine). New York: Cambridge University Press.
- Mol, Annemarie. 2008. The Logic of Care: Health and the Problem of Patient Choice. London New York: Routledge.
- Pizzoli, Silvia F. M., Chiara Renzi, Paola Arnaboldi, William Russell-Edu, and Gabriella Pravettoni. 2019. “From Life-Threatening to Chronic Disease: Is This the Case of Cancers? A Systematic Review.” Cogent Psychology 6 (1): 1577593. doi:https://doi.org/10.1080/23311908.2019.1577593.
- Rabeharisoa, Vololona, Tiago Moreira, and Madeleine Akrich. 2014. “Evidence-Based Activism: Patients,’ Users’ and Activists’ Groups in Knowledge Society.” Biosocieties 9 (2): 111–128. doi:https://doi.org/10.1057/biosoc.2014.2.
- Sarradon-Eck, Aline, Sakoyan, Juliette, Desclaux, Alice, Mancini, Julien, Genre, Dominique and Claire, Julian-Reynier. 2012. “’They should take time’: disclosure of clinical trial results as part of a social relationship”, Social Science & Medicine 75: 873–882. doi:https://doi.org/10.1016/j.socscimed.2012.04.022
- Sinding, Christina, Pamela Hudak, Jennifer Wiernikowski, Jane Aronson, Pat Miller, Judy Gould, and Donna Fitzpatrick-Lewis. 2010. ““I like to be an informed person but.” negotiating responsibility for treatment decisions in cancer care .” Social Science & Medicine (1982) 71 (6): 1094–1101. doi:https://doi.org/10.1016/j.socscimed.2010.06.005.
- Sinding, Christina, Patricia Miller, Pamela Hudak, Sue Keller-Olaman, and Jonathan Sussman. 2012. “Of Time and Troubles: Patient Involvement and the Production of Health Care Disparities.” Health (London, England: 1997) 16 (4): 400–417. doi:https://doi.org/10.1177/1363459311416833.
- Stetz Kathleen, M. 1993. “Survival Work: The Experience of the Patient and the Spouse Involved in Experimental Treatment for Cancer.” Seminars in Oncology Nursing 9 (2): 121–126. doi:https://doi.org/10.1016/S0749-2081(05)80108-1.
- Swallow, Julia, Anne Kerr, Choon Key Chekar, and Sarah Cunningham-Burley. 2020. “Accomplishing an Adaptive Clinical Trial for Cancer: Valuation Practices and Care Work across the Laboratory and the Clinic.” Social Science & Medicine (1982) 252 : 112949. doi:https://doi.org/10.1016/j.socscimed.2020.112949.
- Swan, Melanie. 2009. “Emerging Patient-Driven Health Care Models: An Examination of Health Social Networks, Consumer Personalized Medicine and Quantified Self-Tracking.” International Journal of Environmental Research and Public Health 6 (2): 492–525. doi:https://doi.org/10.3390/ijerph6020492.
- Timmermann, Carsten. 2014. A History of Lung Cancer: The Recalcitrant Disease. Basingstoke: Palgrave Macmillan.
- Thomas, William I., and Florian Znaniecki. 1998. Le Paysan Polonais en Europe et en Amérique, Récit de Vie D’un Migrant. Paris: Nathan.
- Thompson, Charis. 2005. Making Parents. The Ontological Choreography of Reproductive Technologies. Cambridge: MIT Press books.